Kerstin Dehne

Title: Kerstin Dehne: Innovator in Antibody Development

Introduction

Kerstin Dehne is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies targeting the mammalian EAG1 ion channel protein. Her work has implications for diagnosing and treating various diseases.

Latest Patents

Kerstin Dehne holds 1 patent related to her innovative work. The patent is titled "Antibodies directed to the mammalian EAG1 ion channel protein." This invention encompasses a unique antibody, antibody fragment, or derivative that specifically binds to at least one epitope of the extracellular or intracellular domain of the mammalian EAG1 ion channel. The patent also covers nucleic acid molecules encoding these anti-EAG1 antibodies and methods for their preparation. Furthermore, it includes pharmaceutical compositions comprising these antibodies and their applications in diagnosing and treating diseases.

Career Highlights

Kerstin Dehne is affiliated with the Max Planck Society for the Advancement of Science, where she conducts her research. Her work has been instrumental in advancing the understanding of EAG1-expressing cells and their functions.

Collaborations

Throughout her career, Kerstin has collaborated with notable scientists, including Walter Stühmer and Hendrik Knötgen. These collaborations have enriched her research and contributed to the success of her innovative projects.

Conclusion

Kerstin Dehne is a trailblazer in the field of antibody development, with her work paving the way for new diagnostic and therapeutic approaches. Her contributions continue to impact the scientific community and hold promise for future advancements in medicine.